| Michael Ryan Cavalier, | |
|
3635 Vista Ave, Saint Louis, MO 63110-2539 | |
| (314) 577-8777 | |
| Not Available |
| Full Name | Michael Ryan Cavalier |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse - Emergency |
| Location | 3635 Vista Ave, Saint Louis, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023556156 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WE0003X | Registered Nurse - Emergency | 2011038834 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Ryan Cavalier, 7 Trent Park Ct, O Fallon, MO 63368-8093 Ph: () - | Michael Ryan Cavalier, 3635 Vista Ave, Saint Louis, MO 63110-2539 Ph: (314) 577-8777 |
News Archive
The FDA approval of primary human papillomavirus (HPV) testing will provide doctors one more tool to use in cervical cancer screening, a health routine responsible for saving countless lives. As the largest organization of doctors specializing in the treatment of women's cancers, including cervical cancer, the Society of Gynecologic Oncology welcomes new options for detecting and preventing this terrible disease.
Hospital executives are balancing their hopes that expanded coverage will provide a windfall for facilities now burdened by uncompensated care with their fears that government intervention, such as the possible creation of a public insurance option, could cut into their revenues, the Atlanta Journal-Constitution reports.
A gene panel that looks for about 10 times the number of cancer-causing genes as panels currently used to diagnose and fine-tune treatment for a variety of cancers is effective at identifying problematic genes in the most common leukemia, investigators report.
Babies born to mothers whose immune systems had to grapple with a viral assault - even a mild one - have increased risk of brain and central nervous system abnormalities, according to a new study.
The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy.
› Verified 9 days ago
Maryann Signaigo, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4000 Jennings Station Rd, Saint Louis, MO 63121 Phone: 314-679-7880 Fax: 314-679-7876 | |
Tracy Lynn Cropper, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3800 S Broadway, Saint Louis, MO 63118 Phone: 314-772-2205 Fax: 314-772-9264 | |
Michelle Apple, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 546 Kinswood Ln, Saint Louis, MO 63129 Phone: 314-487-2047 | |
Miss Lauren Whitney Stone, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4000 Jennings Station Rd, Saint Louis, MO 63121 Phone: 314-679-7914 | |
Kristin Johnson, RNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 760 Office Pkwy, Saint Louis, MO 63141 Phone: 314-995-4700 Fax: 314-995-4701 | |
Ms. Fereshteh Keshavarz, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4130 Lindell Blvd, Saint Louis, MO 63108 Phone: 314-535-5600 Fax: 314-615-2190 | |
Susan Pollard, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1129 Macklind Ave, Saint Louis, MO 63110 Phone: 314-534-0200 Fax: 314-534-7996 |